In the brain, GLP-1 agonists reduce signalling and activity in the parts of the brain that make food rewarding and tell us that were hungry
Full EVOKE/EVOKE+ results are likely to be discussed further at upcoming scientific meetings (e.g., AD/PD 2026), and ongoing analyses may explore preventive settings (earlier intervention), dose/exposure considerations (e.g., injectable vs
The Honest Answer: How Long Should You Stay on Semaglutide
For researchers serious about optimizing their GLP-1 protocols while managing side effects effectively, SeekPeptides provides comprehensive management guides, symptom tracking tools, and access to a community of experienced users who have navigated these exact challenges
Health Neonatol
August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity